NCT02423759View on ClinicalTrials.gov

A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy

PHASE4CompletedINTERVENTIONAL
Enrollment

510

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

January 16, 2017

Study Completion Date

April 1, 2017

Conditions
Benign Prostate Hyperplasia
Interventions
DRUG

ciprofloxacin

500mg ciprofloxacin twice daily starting the day before biopsy and continued for 3 days after

DRUG

ciprofloxacin and gentamycine

standard chemoprophylaxis plus gentamicin 160mg intramuscular once just before the biopsy

DRUG

culture based chemoprophylaxis

Patients will receive antibiotic according to rectal swab culture at time of biopsy and then after for 3 days.

Trial Locations (1)

35516

Urology and Nprhology Center, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT02423759 - A Trial Assessing Peri-procedure Chemoprophylaxis During Transrectal Prostate Needle Biopsy | Biotech Hunter | Biotech Hunter